Cancer vanishes for every patient in drug trial; Indian-origin patient among those healed completely

A small-scale trial of a drug for cancer treatment has shown 100% success in removing the tumours and preventing recurrence in patients

This new approach of “immunoablative” therapy uses immunotherapy to replace surgery, chemotherapy and radiation to remove cancer

The initial purpose of this study was listed to find out whether the study drug, TSR-042 effective treatment for advanced  (dMMR) solid tumours

The medical trial was supported by the Simon and Eve Colin Foundation, GlaxoSmithKline, Stand Up to Cancer, Swim Across America

Participants of the trial with mismatch repair-deficient stage II or III rectal adenocarcinoma were given the drug every three weeks, for six months

After at least six months of follow-up, all 12 patients showed a clinical complete response with no signs of the tumour

“What’s remarkable here is that it completely eliminated cancer. The tumours just vanished.”